KSCM
WGS icon

Kamunting Street Capital Management’s GeneDx Holdings WGS Stock Holding History

Kamunting Street Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-758
Closed -$350K – 82
2021
Q2 		$350K Buy
+758
New +$325K 0.14% 70

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kamunting Street Capital Management's WGS Position: Q3 2021 in Review

Kamunting Street Capital Management sold out of GeneDx Holdings (WGS) in Q3 2021, closing a stake of 758 shares — an estimated $350K sold.

Kamunting Street Capital Management first reported a position in WGS in Q2 2021 and held it in 1 quarter. The position peaked at $350K in Q2 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q3 2021.

  • Kamunting Street Capital Management reported no remaining GeneDx Holdings position as of Q3 2021 after selling out during the quarter.
  • Kamunting Street Capital Management sold 758 GeneDx Holdings shares in Q3 2021, an estimated $350K.
  • Kamunting Street Capital Management first reported a position in GeneDx Holdings in Q2 2021 and held it in 1 quarter.
  • Kamunting Street Capital Management's GeneDx Holdings position peaked at $350K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2021.

Based on Kamunting Street Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.